Overall, the results of the simulations showed a trend in agreement with the experiments.
← all phrases
“showed a trend”
In the literature
Indeed, treating the cells with PBA a general ER-stress inhibitor showed a trend decrease in TXNIP expression.
LDL-C showed a trend toward reduction at the 26.7 mg/m 2 level, but this did not meet statistical significance.
The rate of both fluorescence increase and compensatory endocytosis after stimulation at 10 Hz for 60 s did not significantly change with loss of LRRK2, but endocytosis showed a trend to acceleration (Figure 5A ).
11 On the other hand, the HPC proteome showed a trend towards downregulation of differentially expressed proteins.
Patients with paroxysmal AF also showed a trend towards the highest troponin I concentrations, although the differences with the other groups were not significant.
Our results showed a trend toward an increase in B. longum after FMT; however, whether FMT induced symbiosis in UC patients is unclear.
In conclusion, although the present study was performed using limited case samples and with some biases, the results obtained showed a trend of elderly GC patients towards surgical therapy.
Moreover, inverse translation studies in mice also showed a trend to lower levels Cd163 ‐PBL in diet induced mildly hypercholesterolaemic animals, and Cd163 ‐expression was highly up‐regulated in mice lacking Lrp5 , suggesting a direct relationship between high LRP5 and low CD163 levels in macrophages of FH patients.
The results showed a trend towards decreased survival with increasing number of unfavourable genotypes.
Although female mice showed a trend for decreased body weight as well, there was no significant difference between mice infected with AAV5-control or AAV5-Cre ( Figure 1 B, AAV5-con, n = 11 mice; AAV5-Cre, n = 11 mice).
The transcription factor aaSTAT was slightly downregulated while the effector gene of this pathway, aaTEP, showed a trend of induction (Fig. 1c ).
In the 500 IR group, all main and subdomains showed a trend of improvement but did not reach statistical significance.
A randomized, double‐blind, placebo‐controlled trial of TAK‐242 showed a trend towards a reduced 28‐day mortality in patients with both septic shock and respiratory failure in the treatment group, but the result was not significant (Rice et al . 2010 ).
1.7 ± 0.9 ng/ml), and showed a trend to express more IL-1β than EMT6 siCD200 tumors (93 ± 66 pg/ml vs. 58 ± 10 pg/ml) with significant individual variability in the data collected ( Fig 2H ).
biceps femoris showed a trend of reduction in running with LEAF.
The PLSR model with pretreatment by SG and SNV performed best in predicting pH while it showed a trend of slight underestimation.
Specifically, IL-6 levels showed a trend toward a further increase under CRC conditions.
The alteration of ΔpH cm showed a trend of reduction in MG-63 cells and a significant reduction in Saos-2 sensitive (P-gp negative) cells when cells were treated with OME (Figure 5C ).
ET-1 levels measured in the aqueous humour of CathA S190A /Scpep1 -/- mice showed a trend for increase as compared with WT mice ( S6 Fig ) but the difference was not statistically significant, consistent with results previously obtained for the blood plasma.
Beta catenin mRNA levels showed a trend of mRNA reduction that did not reach significance ( Fig 6C ).
A significant increase in IL-6 relative to mock-infected controls was also observed at days 3 and 9 (P<0.05) and although IL-1β showed a trend toward an increase at day 3, the differences were not statistically significant.
In our study, preeclampsia/eclampsia showed a trend towards contributing to an increased risk of PM but this result was not statistically significant.
Average generic price discount over originator and the number of biosimilars showed a trend toward statistical significance for correlation with biosimilar uptake, but did not reach the significance threshold.
Likewise, these people had significant higher non-fasting glucose levels and showed a trend toward higher levels of HbA1c and fasting glucose ( Table 1 ).